Table 4 HPV prevalence by cytologic findings and according to age groups in Quilombola women
HPV Detection | p | ||
|---|---|---|---|
Cytologic Finding | Negative n (%) | Positive n (%) | |
Age group (<30 years) | |||
ASC-US | 3 (60.0) | 2 (40.0) | 0.02 |
HSIL | – | 2 (100.0) | |
LSIL | – | 2 (100.0) | |
Inflammation | 83 (76.8) | 25 (23.2) | |
Atrophy | 2 (100.0) | – | |
Total | 88 (74.0) | 31 (26.0) | |
Age group (31–40 years) | |||
ASC-H | – | 2 (100.0) | 0.0009 |
ASC-US | 2 (100.0) | – | |
HSIL | 1 (100.0) | – | |
LSIL | 2 (50.0) | 2 (50.0) | |
Inflammation | 77 (84.6) | 14 (15.4) | |
Atrophy | – | 2 (100.0) | |
Total | 82 (80.4) | 20 (19.6) | |
Age group (41–50 years) | |||
ASC-H | 2 (100.0) | – | 0.03 |
ASC-US | 2 (66.7) | 1 (33.3) | |
HSIL | – | 2 (100.0) | |
LSIL | 1 (100.0) | – | |
Inflammation | 62 (85.0) | 11 (15.0) | |
Atrophy | 1 (50.0) | 1 (50.0) | |
Total | 68 (82.0) | 15 (18.0) | |
Age group (51–60 years) | |||
ASC-H | – | 1 (100.0) | 0.0003 |
ASC-US | 1 (100.0) | – | |
HSIL | 1 (20.0) | 4 (80.0) | |
Inflammation | 49 (90.7) | 5 (9.3) | |
Atrophy | 11 (73.3) | 4 (26.7) | |
Total | 62 (81.5) | 14 (18.5) | |
Age group (>60 years) | |||
ASC-US | – | 1 (100.0) | 0.12 |
LSIL | 1 (100.0) | – | |
Inflammation | 19 (82.6) | 4 (17.4) | |
Atrophy | 10 (90.9) | 1 (9.1) | |
Total | 20 (80.0) | 5 (20.0) | |